Fingerprint
Dive into the research topics of 'What does ATLAS really tell us about 'high' dose angiotensin-converting enzyme inhibition in heart failure?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
What does ATLAS really tell us about 'high' dose angiotensin-converting enzyme inhibition in heart failure?
John M. Nicklas, Jay N. Cohn, Bertram Pitt
Research output: Contribution to journal › Review article › peer-review
7
Scopus
citations